
- Telehealth Visits
- Insurance plan information
- Provider Type: Physician

Michael P. Randall, MD
Hematology and Medical Oncology- Telehealth Visits
- Insurance plan information
- Provider Type: Physician



Michael P. Randall, MD
Hematology and Medical OncologyOn this page
About me
Dr. Michael P. Randall is a medical oncologist who cares for patients with blood cancers, such as Hodgkin and non-Hodgkin lymphoma as well as chronic lymphocytic leukemia. He is experienced in using immune-based therapies to treat lymphoma that returns or doesn't respond to treatment, including stem cell transplantation and immune effector cell therapies (reprogramming immune cells to better attack tumor cells) such as CAR T-cell therapy. He has a particular interest in lymphomas affecting the central nervous system (brain and spinal cord), which can be challenging to treat and require different treatment strategies than that of lymphomas affecting the rest of the body.
In research, Randall is involved in several clinical trials testing new therapies for lymphoma, with a particular focus on forms of the disease affecting the central nervous system. He is especially interested in correlative science, which involves discovering new biomarkers to diagnose and monitor diseases like lymphoma. He also collaborates with scientists in the lab to understand why certain treatments work for some patients and not others. During his fellowship, he developed the first clinical trial using circulating tumor DNA to inform therapy in relapsed Hodgkin lymphoma.
Randall earned his medical degree at the Perelman School of Medicine at the University of Pennsylvania. He completed a residency in internal medicine at Johns Hopkins Hospital and a fellowship in medical oncology at UCSF.
Education & training
Board certification
- Internal Medicine, American Board of Internal Medicine
Residency
- Internal Medicine, Johns Hopkins University School of Medicine - GME
Internship
- Internal Medicine, Johns Hopkins University School of Medicine - GME
Degree
- MD, Perelman School of Medicine University of Pennsylvania
Academic title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Clinical trials
PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T TherapyOpens in a new window
Recruiting
The proportion of known lesions with detectable radiotracer uptake on conventional imaging will be reported along with 95% binomial exact confidence intervals....
Publications
Showing 1-6 of 20 reviews
- September 26, 20265 out of 5 Stars
Again, Dr. Randall, my oncologist continues to provide excellent compassion care answers all my questions, intelligent manner, and more importantly, he gives me reasons why I have moments of doubt, depression. He attributes some of my fatigue and depression to the use of the Lupron injections, which keep the testosterone levels at bay for my prostate cancer. He suggested I contact my primary care physician and my urologist if I have any other questions that that need to be answered, but basically Doctor Randall and Staff are absolutely perfect. In every way. I'm so pleased to have them in my corner.
- September 25, 20264.8 out of 5 Stars
Felt the warm with the nurses & doctors
- September 22, 20264 out of 5 Stars
Dr. Randall is a good egg
- September 19, 20264 out of 5 Stars
Dr Randall is new to me referred by Dr. Sayre. Dr. Randall Has been supportive.
- September 17, 20265 out of 5 Stars
Excellent visit. Took the time to answer my questions in detail. He was clear and articulate and I was very impressed by him.
- August 30, 20265 out of 5 Stars
Dr.Randall's approach to asking and responding to questions was exceptional!
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.